Health · Medical Research · 3 hrs ago
Early studies suggest promise for cardiac microcurrent therapy in heart failure
Cardiac microcurrent therapy is being studied for heart failure, a condition in which the heart does not pump blood as well as it should.
The therapy is also called C-MIC.
Early studies have prompted interest in its potential benefits, while evidence is still accumulating.
The treatment’s promise has been described as almost too good to be true.
The available information does not say what benefits were measured or how many patients were studied.
More evidence is needed to understand how well the therapy works.
Early studies suggest cardiac microcurrent therapy may have promise for heart failure.
The therapy is referred to as cardiac microcurrent, or C-MIC.
The report says C-MIC met more objective criteria as evidence accrued.
The report was published by MedPage Today on October 13, 2026.
- Who
- Not stated.
- What
- Early studies suggest cardiac microcurrent therapy may have promise for heart failure.
- When
- The report was published October 13, 2026.
- Where
- Phoenix, according to the article dateline.
- Why
- The therapy is being studied for heart failure.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Therapy
- Cardiac microcurrent (C-MIC)
- Condition
- Heart failure
- Publication date
- October 13, 2026
- Article dateline
- Phoenix
What people are saying
too good to be true
Sources
Related news
Pope Leo XIV diagnosed with lung cancer after surgery in Rome
Davina McCall describes severe memory loss after brain tumour surgery
Blocking an immune pathway protected brain tissue in mice with tau buildup
Study finds body changes begin years before the last menstrual period
Daily egg intake linked to lower Alzheimer’s risk in older adults
Studies find more cancer diagnoses among people under 50
Science Corporation implants vision chip in first Stargardt disease patient
Two studies raise concerns about Ozempic, Mounjaro and hair and nails
Meat-derived sugar linked to higher diabetes risk in French study
Lola Weippert says doctors found a tumour in her right breast
Greater gut bacteria diversity linked to lower frailty in older women
